Amrit Ray - 19 Apr 2022 Form 3 Insider Report for Ultragenyx Pharmaceutical Inc. (RARE)

Role: Director
Signature: /s/ Karah Parschauer, attorney-in-fact
Issuer symbol: RARE
Transactions as of: 19 Apr 2022
Net transactions value: $0
Form type: 3
Filing time: 22 Apr 2022, 12:30:18 UTC
Next filing: 28 Jun 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

No securities beneficially owned